Article Replacement Under Process

“Ethical Issues in Cell and Gene Therapy Using CRISPR/Cas9 System”

Article has been withdrawn by Corresponding and Co - Authours. Approved by InnovationInfo Publishing

Corresponding author: Dr. Hui-Fang Li, Science and Technology Policy Research and Information Center (STPI), National Applied Research Laboratories (NARLabs), Taipei, Taiwan. Tel: 886- 02-27377177; Email: hfli(at)stpi.narl.org.tw